| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of organelle organization | CRACD RND1 MYCBP2 MAP4 WASF2 MKI67 HIP1R NAV3 SMARCC2 TSC2 ESPL1 SYDE1 SPAG5 | 1.30e-05 | 1342 | 50 | 13 | GO:0033043 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 5.08e-05 | 720 | 50 | 9 | GO:0000226 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 6.58e-05 | 421 | 50 | 7 | GO:0010639 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 6.98e-05 | 579 | 50 | 8 | GO:0051493 | |
| GeneOntologyCellularComponent | microtubule end | 1.09e-04 | 38 | 51 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | supramolecular fiber | 4.82e-04 | 1179 | 51 | 10 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 5.08e-04 | 1187 | 51 | 10 | GO:0099081 | |
| HumanPheno | Cardiac rhabdomyoma | 5.07e-05 | 5 | 12 | 2 | HP:0009729 | |
| HumanPheno | Rhabdomyoma | 5.07e-05 | 5 | 12 | 2 | HP:0009730 | |
| Domain | Myb_DNA-binding | 3.80e-03 | 35 | 49 | 2 | PF00249 | |
| Domain | MYB_LIKE | 4.46e-03 | 38 | 49 | 2 | PS50090 | |
| Domain | SANT | 7.62e-03 | 50 | 49 | 2 | SM00717 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.48e-04 | 439 | 38 | 7 | MM15595 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.72e-04 | 450 | 38 | 7 | M27078 | |
| Pubmed | SOX6 SP2 SUPT20H ATXN7L2 CDC42BPA FOXP2 RRP1B NACA MKI67 SMARCC2 ZC3H18 UBN2 SRRM2 MYBL2 | 1.50e-08 | 1429 | 52 | 14 | 35140242 | |
| Pubmed | An epigenetic circuit controls neurogenic programs during neocortex development. | 2.11e-08 | 20 | 52 | 4 | 35020876 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP31 SRRM1 DENND4A CDC42BPA MYCBP2 MAP4 KIAA1217 TSC2 SRRM2 NCKAP5L SYDE1 | 4.81e-08 | 861 | 52 | 11 | 36931259 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 6.30e-08 | 361 | 52 | 8 | 30344098 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.30e-08 | 361 | 52 | 8 | 26167880 | |
| Pubmed | 8.30e-08 | 246 | 52 | 7 | 15345747 | ||
| Pubmed | DLGAP2 CDC42BPA MYCBP2 MAP4 KIAA1217 NACA HIP1R NAV3 DAG1 SMARCC2 ANKLE2 CAP1 | 8.85e-08 | 1139 | 52 | 12 | 36417873 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SRRM1 MYCBP2 MAP4 MKI67 SMARCC2 ZC3H18 ESPL1 SRRM2 PRG4 MYBL2 | 1.91e-07 | 774 | 52 | 10 | 15302935 |
| Pubmed | 4.92e-07 | 653 | 52 | 9 | 22586326 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 6.09e-07 | 108 | 52 | 5 | 19531213 | |
| Pubmed | 6.87e-07 | 12 | 52 | 3 | 20181597 | ||
| Pubmed | Mitotic spindle regulation by Nde1 controls cerebral cortical size. | 6.87e-07 | 12 | 52 | 3 | 15473967 | |
| Pubmed | 9.03e-07 | 513 | 52 | 8 | 25798074 | ||
| Pubmed | Directional neuronal migration is impaired in mice lacking adenomatous polyposis coli 2. | 1.42e-06 | 15 | 52 | 3 | 22573669 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.74e-06 | 560 | 52 | 8 | 21653829 | |
| Pubmed | 1.74e-06 | 16 | 52 | 3 | 29764992 | ||
| Pubmed | 1.74e-06 | 16 | 52 | 3 | 29255003 | ||
| Pubmed | 1.74e-06 | 16 | 52 | 3 | 27798843 | ||
| Pubmed | Neural development is dependent on the function of specificity protein 2 in cell cycle progression. | 2.11e-06 | 17 | 52 | 3 | 23293287 | |
| Pubmed | Age-related changes in Ki-67 and DCX expression in the BALB/ c mouse (Mus Musculus) brain. | 2.19e-06 | 2 | 52 | 2 | 30472241 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 19710359 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 18761331 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 10668804 | ||
| Pubmed | Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers. | 2.19e-06 | 2 | 52 | 2 | 28766905 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 18649926 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRRM1 SP2 TICRR SUPT20H ATXN7L2 RRP1B MKI67 ZC3H18 UBN2 SRRM2 MYBL2 | 2.69e-06 | 1294 | 52 | 11 | 30804502 |
| Pubmed | 3.00e-06 | 19 | 52 | 3 | 22028625 | ||
| Pubmed | Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models. | 3.00e-06 | 19 | 52 | 3 | 23744272 | |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 3.12e-06 | 270 | 52 | 6 | 24366813 | |
| Pubmed | 4.00e-06 | 1084 | 52 | 10 | 11544199 | ||
| Pubmed | 4.11e-06 | 21 | 52 | 3 | 24483844 | ||
| Pubmed | The apical complex couples cell fate and cell survival to cerebral cortical development. | 4.76e-06 | 22 | 52 | 3 | 20399730 | |
| Pubmed | 4.76e-06 | 22 | 52 | 3 | 33899739 | ||
| Pubmed | JPH1 SRRM1 SUPT20H ATXN7L2 FOXP2 CCNB3 SMARCC2 ZC3H18 SRRM2 NCKAP5L | 5.16e-06 | 1116 | 52 | 10 | 31753913 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 21098484 | ||
| Pubmed | 9.02e-06 | 87 | 52 | 4 | 33798452 | ||
| Pubmed | 9.66e-06 | 329 | 52 | 6 | 17474147 | ||
| Pubmed | 1.01e-05 | 506 | 52 | 7 | 30890647 | ||
| Pubmed | 1.01e-05 | 28 | 52 | 3 | 18794345 | ||
| Pubmed | Full function of exon junction complex factor, Rbm8a, is critical for interneuron development. | 1.01e-05 | 28 | 52 | 3 | 33154347 | |
| Pubmed | Chromatin regulation by BAF170 controls cerebral cortical size and thickness. | 1.01e-05 | 28 | 52 | 3 | 23643363 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.08e-05 | 954 | 52 | 9 | 36373674 | |
| Pubmed | 1.16e-05 | 963 | 52 | 9 | 28671696 | ||
| Pubmed | 1.22e-05 | 731 | 52 | 8 | 29298432 | ||
| Pubmed | 1.24e-05 | 30 | 52 | 3 | 22056141 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 10908574 | ||
| Pubmed | Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex. | 1.31e-05 | 4 | 52 | 2 | 14559897 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 18205207 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.41e-05 | 533 | 52 | 7 | 30554943 | |
| Pubmed | Dlx1/2-dependent expression of Meis2 promotes neuronal fate determination in the mammalian striatum. | 1.52e-05 | 32 | 52 | 3 | 35156680 | |
| Pubmed | 1.58e-05 | 210 | 52 | 5 | 16565220 | ||
| Pubmed | Cenpj Regulates Cilia Disassembly and Neurogenesis in the Developing Mouse Cortex. | 1.67e-05 | 33 | 52 | 3 | 30626697 | |
| Pubmed | 1.76e-05 | 103 | 52 | 4 | 10574462 | ||
| Pubmed | 1.83e-05 | 34 | 52 | 3 | 34963132 | ||
| Pubmed | Ndrg2 expression in neurogenic germinal zones of embryonic and postnatal mouse brain. | 2.19e-05 | 5 | 52 | 2 | 22143493 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 27701470 | ||
| Pubmed | p75NTR prevents the onset of cerebellar granule cell migration via RhoA activation. | 2.19e-05 | 5 | 52 | 2 | 36040414 | |
| Pubmed | Nrf2 Transcriptional Activity Governs Intestine Development. | 2.19e-05 | 5 | 52 | 2 | 35682851 | |
| Pubmed | 2.29e-05 | 227 | 52 | 5 | 26410627 | ||
| Pubmed | Lysine acetylation targets protein complexes and co-regulates major cellular functions. | 2.56e-05 | 38 | 52 | 3 | 19608861 | |
| Pubmed | Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala. | 2.56e-05 | 38 | 52 | 3 | 38086370 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRRM1 SUPT20H CDC42BPA RRP1B MYCBP2 SMARCC2 ZC3H18 SRRM2 DCX | 2.92e-05 | 1082 | 52 | 9 | 38697112 |
| Pubmed | 3.12e-05 | 242 | 52 | 5 | 34011540 | ||
| Pubmed | Spatially dependent dynamic MAPK modulation by the Nde1-Lis1-Brap complex patterns mammalian CNS. | 3.23e-05 | 41 | 52 | 3 | 23673330 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.26e-05 | 608 | 52 | 7 | 36089195 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 32000863 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 9531537 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 11245989 | ||
| Pubmed | DNA Methyltransferase 1 Is Indispensable for Development of the Hippocampal Dentate Gyrus. | 3.28e-05 | 6 | 52 | 2 | 27251626 | |
| Pubmed | 3.64e-05 | 250 | 52 | 5 | 33536335 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 3.67e-05 | 853 | 52 | 8 | 28718761 | |
| Pubmed | 3.73e-05 | 43 | 52 | 3 | 27664421 | ||
| Pubmed | 3.86e-05 | 421 | 52 | 6 | 36976175 | ||
| Pubmed | 4.00e-05 | 255 | 52 | 5 | 15324660 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 4.00e-05 | 1415 | 52 | 10 | 28515276 | |
| Pubmed | 4.25e-05 | 634 | 52 | 7 | 34591612 | ||
| Pubmed | Osterix is dispensable for the development of the mouse olfactory bulb. | 4.58e-05 | 7 | 52 | 2 | 27449610 | |
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 17959791 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 22798074 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 25297105 | ||
| Pubmed | 4.58e-05 | 7 | 52 | 2 | 18755297 | ||
| Pubmed | 4.80e-05 | 133 | 52 | 4 | 15144186 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 4.85e-05 | 1155 | 52 | 9 | 20360068 | |
| Pubmed | JPH1 USP31 SRRM1 CDC42BPA RRP1B MYCBP2 ESPL1 SRRM2 NCKAP5L ANKLE2 | 6.07e-05 | 1487 | 52 | 10 | 33957083 | |
| Pubmed | Development of the adult neurogenic niche in the hippocampus of mice. | 6.10e-05 | 8 | 52 | 2 | 25999820 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 16777961 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 35685988 | ||
| Pubmed | A single-cell transcriptomic landscape of cadmium-hindered brain development in mice. | 6.10e-05 | 8 | 52 | 2 | 39147853 | |
| Pubmed | TRIP6 regulates neural stem cell maintenance in the postnatal mammalian subventricular zone. | 6.10e-05 | 8 | 52 | 2 | 25044744 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 18031938 | ||
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 35660973 | ||
| Pubmed | Critical role of the BAF chromatin remodeling complex during murine neural crest development. | 6.10e-05 | 8 | 52 | 2 | 33750945 | |
| Pubmed | miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. | 6.10e-05 | 8 | 52 | 2 | 19287386 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 36843845 | ||
| Pubmed | Klotho regulates postnatal neurogenesis and protects against age-related spatial memory loss. | 6.10e-05 | 8 | 52 | 2 | 28837861 | |
| Pubmed | Nuclear receptor TLX regulates cell cycle progression in neural stem cells of the developing brain. | 6.10e-05 | 8 | 52 | 2 | 17901127 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 28438606 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | JPH1 SRRM1 RRP1B MYCBP2 KIAA1217 ITSN2 TSC2 ESPL1 SRRM2 ANKLE2 | 6.38e-05 | 1496 | 52 | 10 | 32877691 |
| Pubmed | CRACD SUPT20H CDC42BPA RRP1B MAP4 WASF2 NACA ITSN2 HIP1R UBN2 | 6.42e-05 | 1497 | 52 | 10 | 31527615 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 36764294 | ||
| Interaction | NUP43 interactions | 3.74e-06 | 625 | 52 | 10 | int:NUP43 | |
| Interaction | DCTN1 interactions | 4.50e-06 | 497 | 52 | 9 | int:DCTN1 | |
| Interaction | YWHAE interactions | USP31 CRACD TICRR DENND4A CDC42BPA MYCBP2 SMARCC2 TSC2 ZC3H18 SRRM2 NCKAP5L DCX SYDE1 | 1.30e-05 | 1256 | 52 | 13 | int:YWHAE |
| Interaction | SH3KBP1 interactions | 1.56e-05 | 315 | 52 | 7 | int:SH3KBP1 | |
| Interaction | SIRT7 interactions | SRRM1 RRP1B MYCBP2 MAP4 WASF2 MKI67 SMARCC2 ZC3H18 SRRM2 CAP1 | 1.72e-05 | 744 | 52 | 10 | int:SIRT7 |
| Interaction | YWHAH interactions | USP31 SRRM1 TICRR DENND4A CDC42BPA MYCBP2 WASF2 KIAA1217 TSC2 SRRM2 NCKAP5L SYDE1 | 1.82e-05 | 1102 | 52 | 12 | int:YWHAH |
| Interaction | SNRNP40 interactions | 3.25e-05 | 637 | 52 | 9 | int:SNRNP40 | |
| Interaction | SF3B5 interactions | 3.33e-05 | 143 | 52 | 5 | int:SF3B5 | |
| Interaction | BRD3 interactions | 3.59e-05 | 494 | 52 | 8 | int:BRD3 | |
| Interaction | YWHAG interactions | USP31 SRRM1 CRACD TICRR DENND4A CDC42BPA MYCBP2 WASF2 TSC2 SRRM2 NCKAP5L SYDE1 | 6.16e-05 | 1248 | 52 | 12 | int:YWHAG |
| Interaction | SFN interactions | USP31 DENND4A CDC42BPA MYCBP2 MAP4 TSC2 ZC3H18 SRRM2 NCKAP5L | 6.17e-05 | 692 | 52 | 9 | int:SFN |
| Interaction | PPP1CA interactions | 6.46e-05 | 696 | 52 | 9 | int:PPP1CA | |
| Interaction | KCNA3 interactions | JPH1 SRRM1 CDC42BPA MAP4 WASF2 COL27A1 NACA ZC3H18 ANKLE2 CAP1 | 6.55e-05 | 871 | 52 | 10 | int:KCNA3 |
| Interaction | WDR48 interactions | 9.19e-05 | 177 | 52 | 5 | int:WDR48 | |
| Interaction | PPP1CC interactions | 1.01e-04 | 738 | 52 | 9 | int:PPP1CC | |
| Interaction | CCNA2 interactions | 1.08e-04 | 183 | 52 | 5 | int:CCNA2 | |
| Interaction | LIMA1 interactions | 1.10e-04 | 429 | 52 | 7 | int:LIMA1 | |
| Interaction | NEK4 interactions | 1.13e-04 | 582 | 52 | 8 | int:NEK4 | |
| Interaction | DCX interactions | 1.19e-04 | 98 | 52 | 4 | int:DCX | |
| Interaction | PABPN1 interactions | 1.35e-04 | 192 | 52 | 5 | int:PABPN1 | |
| Interaction | FEV interactions | 1.75e-04 | 203 | 52 | 5 | int:FEV | |
| Interaction | BARD1 interactions | 1.77e-04 | 323 | 52 | 6 | int:BARD1 | |
| Interaction | SOX2 interactions | SOX6 SP2 CDC42BPA RRP1B KIAA1217 HIP1R NAV3 SMARCC2 CPLANE1 UBN2 CAP1 MYBL2 | 2.13e-04 | 1422 | 52 | 12 | int:SOX2 |
| Interaction | FSD2 interactions | 2.21e-04 | 115 | 52 | 4 | int:FSD2 | |
| Interaction | NEURL4 interactions | 2.28e-04 | 116 | 52 | 4 | int:NEURL4 | |
| Interaction | YWHAB interactions | USP31 TICRR DENND4A CDC42BPA MYCBP2 WASF2 TSC2 SRRM2 NCKAP5L SYDE1 | 2.29e-04 | 1014 | 52 | 10 | int:YWHAB |
| Interaction | SMARCA2 interactions | 2.57e-04 | 346 | 52 | 6 | int:SMARCA2 | |
| Interaction | PHLDB1 interactions | 2.75e-04 | 49 | 52 | 3 | int:PHLDB1 | |
| Interaction | DCLK1 interactions | 3.22e-04 | 127 | 52 | 4 | int:DCLK1 | |
| Interaction | HDAC2 interactions | 3.31e-04 | 865 | 52 | 9 | int:HDAC2 | |
| Interaction | GSK3B interactions | 3.40e-04 | 868 | 52 | 9 | int:GSK3B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.18e-04 | 423 | 52 | 5 | chr12q13 | |
| Cytoband | 3p21 | 6.50e-04 | 33 | 52 | 2 | 3p21 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.93e-03 | 181 | 25 | 3 | 694 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.42e-03 | 53 | 25 | 2 | 532 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 2.41e-06 | 108 | 52 | 5 | MM1334 | |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 1.02e-05 | 68 | 52 | 4 | M41108 | |
| Coexpression | GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP | 2.97e-05 | 181 | 52 | 5 | M6814 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 4.22e-05 | 323 | 52 | 6 | M2156 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 4.67e-05 | 199 | 52 | 5 | M7549 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 4.78e-05 | 200 | 52 | 5 | M3580 | |
| Coexpression | PEREZ_TP53_TARGETS | JPH1 SOX6 CRACD AKTIP KIAA1217 COL27A1 ITSN2 HIP1R TSC2 MUC2 | 1.07e-04 | 1201 | 52 | 10 | M4391 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | 1.11e-04 | 385 | 52 | 6 | M2840 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SOX6 SRRM1 CRACD SP2 TICRR AKTIP CDC42BPA RRP1B MKI67 CPLANE1 NCKAP5L DCX SPAG5 MYBL2 | 3.52e-06 | 1370 | 52 | 14 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SOX6 SRRM1 CRACD TICRR AKTIP FOXP2 RRP1B MKI67 CPLANE1 UBN2 SPAG5 MYBL2 | 3.98e-05 | 1257 | 52 | 12 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.99e-05 | 90 | 52 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 7.39e-05 | 178 | 52 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX6 SRRM1 CRACD TICRR AKTIP FOXP2 RRP1B MKI67 CPLANE1 UBN2 SPAG5 MYBL2 | 1.66e-04 | 1459 | 52 | 12 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SRRM1 CRACD TICRR RND1 FOXP2 RRP1B MKI67 SMARCC2 CPLANE1 DCX PCYT1B | 1.85e-04 | 1252 | 52 | 11 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-08 | 164 | 52 | 6 | fb18b863152fb3109e2224c791c84c6371680a4e | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-08 | 165 | 52 | 6 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 4.08e-08 | 166 | 52 | 6 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 4.08e-08 | 166 | 52 | 6 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-06 | 169 | 52 | 5 | dbf9b1d52b29bf4b60bd23012cc1ea82d344747f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-06 | 169 | 52 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 173 | 52 | 5 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.94e-06 | 176 | 52 | 5 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.94e-06 | 176 | 52 | 5 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.11e-06 | 179 | 52 | 5 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-06 | 180 | 52 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.47e-06 | 185 | 52 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-06 | 189 | 52 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 2.82e-06 | 190 | 52 | 5 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 2.89e-06 | 191 | 52 | 5 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 3.04e-06 | 193 | 52 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.12e-06 | 194 | 52 | 5 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.12e-06 | 194 | 52 | 5 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.12e-06 | 194 | 52 | 5 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.12e-06 | 194 | 52 | 5 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.12e-06 | 194 | 52 | 5 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.12e-06 | 194 | 52 | 5 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 3.12e-06 | 194 | 52 | 5 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.12e-06 | 194 | 52 | 5 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.12e-06 | 194 | 52 | 5 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.20e-06 | 195 | 52 | 5 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.20e-06 | 195 | 52 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.20e-06 | 195 | 52 | 5 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.20e-06 | 195 | 52 | 5 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.20e-06 | 195 | 52 | 5 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 3.28e-06 | 196 | 52 | 5 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.28e-06 | 196 | 52 | 5 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.28e-06 | 196 | 52 | 5 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 3.28e-06 | 196 | 52 | 5 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.28e-06 | 196 | 52 | 5 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.28e-06 | 196 | 52 | 5 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.36e-06 | 197 | 52 | 5 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.36e-06 | 197 | 52 | 5 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.36e-06 | 197 | 52 | 5 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.36e-06 | 197 | 52 | 5 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.36e-06 | 197 | 52 | 5 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 3.36e-06 | 197 | 52 | 5 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.36e-06 | 197 | 52 | 5 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.36e-06 | 197 | 52 | 5 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.36e-06 | 197 | 52 | 5 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.36e-06 | 197 | 52 | 5 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Cycling_T|lymph-node_spleen / Manually curated celltypes from each tissue | 3.36e-06 | 197 | 52 | 5 | aca6cbff7391ff550061bb7daa67fc5f6585806a | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.36e-06 | 197 | 52 | 5 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.36e-06 | 197 | 52 | 5 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.36e-06 | 197 | 52 | 5 | 47be19f595135da248469b2e21b8d88f561827b2 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 3.36e-06 | 197 | 52 | 5 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.36e-06 | 197 | 52 | 5 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.36e-06 | 197 | 52 | 5 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 3.36e-06 | 197 | 52 | 5 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.45e-06 | 198 | 52 | 5 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.45e-06 | 198 | 52 | 5 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 3.45e-06 | 198 | 52 | 5 | 47d572b9db2843aeb2079f33a852babf67270be4 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.45e-06 | 198 | 52 | 5 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.45e-06 | 198 | 52 | 5 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.45e-06 | 198 | 52 | 5 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.45e-06 | 198 | 52 | 5 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 3.45e-06 | 198 | 52 | 5 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.45e-06 | 198 | 52 | 5 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 3.53e-06 | 199 | 52 | 5 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | MNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 3.53e-06 | 199 | 52 | 5 | 5952980d0ece5d73f3e9f340c56a38b34d2f2309 | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 3.53e-06 | 199 | 52 | 5 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-06 | 199 | 52 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 3.53e-06 | 199 | 52 | 5 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.62e-06 | 200 | 52 | 5 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-T/NK_proliferative|Multiple_Sclerosis / Disease, condition lineage and cell class | 3.62e-06 | 200 | 52 | 5 | 7faf1e37364203a08d2b2544979e848b41e36b1c | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.62e-06 | 200 | 52 | 5 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.62e-06 | 200 | 52 | 5 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-06 | 200 | 52 | 5 | 2afbb5b5742b956993796621fea7e0c9888754a1 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 3.62e-06 | 200 | 52 | 5 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | medial-Hematologic-Proliferating_NK/T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.62e-06 | 200 | 52 | 5 | ab1f9f99cb4a381a642a2cfb32e7f8d276c2dda4 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.62e-06 | 200 | 52 | 5 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.62e-06 | 200 | 52 | 5 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-06 | 200 | 52 | 5 | 4462ebd5d4632788f10a93fadd2babae701c754f | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.62e-06 | 200 | 52 | 5 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | medial-Hematologic-Proliferating_NK/T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.62e-06 | 200 | 52 | 5 | bfde42e00a9a6b858937de87cd19c9ed3677d954 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_T_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.62e-06 | 200 | 52 | 5 | dd374e153106fff8a22483ba7f63b3fa3d3ab2ea | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.62e-06 | 200 | 52 | 5 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.62e-06 | 200 | 52 | 5 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | medial-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.62e-06 | 200 | 52 | 5 | 3d1895490dd262e9246eb280938239a7253451dd | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-05 | 134 | 52 | 4 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 157 | 52 | 4 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.93e-05 | 163 | 52 | 4 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 163 | 52 | 4 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.02e-05 | 164 | 52 | 4 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-05 | 164 | 52 | 4 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 167 | 52 | 4 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-05 | 167 | 52 | 4 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.31e-05 | 167 | 52 | 4 | 9280558baddea51aae47f3383d895a9b0c6749a4 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-05 | 168 | 52 | 4 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-05 | 168 | 52 | 4 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 168 | 52 | 4 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.52e-05 | 169 | 52 | 4 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-05 | 170 | 52 | 4 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.73e-05 | 171 | 52 | 4 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| Computational | Neighborhood of ESPL1 | 9.80e-05 | 35 | 28 | 3 | GNF2_ESPL1 | |
| Computational | Neighborhood of CENPE | 1.58e-04 | 41 | 28 | 3 | GNF2_CENPE | |
| Computational | Neighborhood of CDC20 | 4.00e-04 | 56 | 28 | 3 | GNF2_CDC20 | |
| Computational | Neighborhood of PCNA | 7.08e-04 | 68 | 28 | 3 | GNF2_PCNA | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 5.36e-06 | 195 | 52 | 6 | 5820_DN | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; HL60; HG-U133A | 5.36e-06 | 195 | 52 | 6 | 1983_DN | |
| Drug | Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A | 5.68e-06 | 197 | 52 | 6 | 6251_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 6.02e-06 | 199 | 52 | 6 | 7030_DN | |
| Disease | mucositis (biomarker_via_orthology) | 2.80e-05 | 5 | 50 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | Barrett's esophagus (is_marker_for) | 1.53e-04 | 11 | 50 | 2 | DOID:9206 (is_marker_for) | |
| Disease | Alzheimer disease, educational attainment | 8.16e-04 | 247 | 50 | 4 | EFO_0011015, MONDO_0004975 | |
| Disease | lissencephaly (implicated_via_orthology) | 9.61e-04 | 27 | 50 | 2 | DOID:0050453 (implicated_via_orthology) | |
| Disease | Carcinoma, Granular Cell | 1.01e-03 | 116 | 50 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.01e-03 | 116 | 50 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.01e-03 | 116 | 50 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.01e-03 | 116 | 50 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.01e-03 | 116 | 50 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.01e-03 | 116 | 50 | 3 | C0001418 | |
| Disease | cytotoxicity measurement, response to clozapine | 1.11e-03 | 29 | 50 | 2 | EFO_0006952, GO_0097338 | |
| Disease | Bladder Neoplasm | 1.74e-03 | 140 | 50 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.78e-03 | 141 | 50 | 3 | C0005684 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.00e-03 | 147 | 50 | 3 | DOID:9352 (biomarker_via_orthology) | |
| Disease | colon cancer (biomarker_via_orthology) | 2.00e-03 | 39 | 50 | 2 | DOID:219 (biomarker_via_orthology) | |
| Disease | multiple system atrophy | 2.11e-03 | 40 | 50 | 2 | EFO_1001050 | |
| Disease | age at diagnosis, osteonecrosis | 2.54e-03 | 44 | 50 | 2 | EFO_0004259, EFO_0004918 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 2.98e-03 | 352 | 50 | 4 | EFO_0007014 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKTSLPLSPVKTAPL | 261 | Q86XL3 | |
| PSIPKNALPITKPTS | 41 | Q9H8T0 | |
| SKKNVPTSPRTSPSP | 151 | A6NJG6 | |
| SAPKPQTSPSPKRAT | 301 | Q01518 | |
| SSPKTSPKSAILPEP | 451 | Q9P1A6 | |
| PSPSFSKLPPSKASK | 541 | Q5T6C5 | |
| PPQSSKPVPKKSQSS | 6 | Q8WWL7 | |
| SLPPNSPKPVRLTKS | 1251 | Q7Z401 | |
| RPVSVPSSKKPPSLQ | 176 | Q9NS23 | |
| SPKKALLPPTVSLSA | 826 | Q9NZM3 | |
| VNPKPLQSSRPSPSK | 6 | Q6NXN4 | |
| PSSRSPSTLLPKKPT | 821 | P27816 | |
| KPNKSPHSSPTKLPS | 806 | Q9HCH0 | |
| PHSSPTKLPSKSPTK | 811 | Q9HCH0 | |
| SSGTPSKNLPKTKPP | 1136 | Q9HCH0 | |
| PASSPKPLKKQNPSS | 476 | Q9HDC5 | |
| KPRVSTPKPATPSTD | 426 | Q14118 | |
| LPLKTSPPSSPKAAS | 341 | Q9Y5K3 | |
| PSKSTPTPSKPSSTP | 4386 | Q02817 | |
| TNSSPKVSPKLAPPK | 436 | Q8IVL0 | |
| PKPSPKPLNLVSSVT | 416 | O15409 | |
| VKSQSKSNTSLPPLP | 2981 | P46013 | |
| PSTAPRSVTTKKPPL | 1026 | O75146 | |
| PSTNSSPVLKTKPQP | 1121 | Q14674 | |
| QTKPSPCKSTQPKPS | 981 | Q9BX69 | |
| KPLPNKPSPTQSSSC | 2986 | Q9H799 | |
| KPTSQTPPASPLSKL | 966 | Q6ZU35 | |
| TPKSKQSPISTPTSP | 326 | O43602 | |
| KPSAPSTSIVPIKSP | 371 | Q8IZC6 | |
| PIKSPHPTQKTAPSS | 381 | Q8IZC6 | |
| APASPPTKASRTKSP | 146 | Q6ZW31 | |
| KLSLSLSPSPQTGKP | 6 | Q96R06 | |
| SSPASSPLVAKKPLT | 731 | Q14684 | |
| RSSSSPPPKQKSKTP | 816 | Q9UQ35 | |
| PSPLPQKSPVRSLSK | 191 | Q92730 | |
| PKSTPVKTLPFSPSQ | 441 | P10244 | |
| KPTSPSLPASKIPAL | 1791 | Q5T5P2 | |
| SPKPKTLPANRSSPS | 2821 | O75592 | |
| SSPPSPASPRKTKSL | 1706 | Q5VT25 | |
| RSPSPSPTPEAKKKN | 301 | Q8TAQ2 | |
| IKSAPTTPKEPAPTT | 371 | Q92954 | |
| TTPKEPAPTTTKSAP | 376 | Q92954 | |
| PAPTTTKSAPTTPKE | 381 | Q92954 | |
| TKSAPTTPKEPAPTT | 386 | Q92954 | |
| APTTTKSAPTTPKEP | 421 | Q92954 | |
| PTTPKEPAPTTTKSA | 516 | Q92954 | |
| EPAPTTTKSAPTTPK | 536 | Q92954 | |
| TTKSAPTTPKEPSPT | 541 | Q92954 | |
| TAPTTPKKLTPTTPE | 616 | Q92954 | |
| PTSTTSDKPAPTTPK | 741 | Q92954 | |
| TAPTTLKEPAPTTPK | 781 | Q92954 | |
| SKTSPVNLPNKSSIP | 451 | P35712 | |
| LSESKKSSPTPNPPI | 1116 | Q96JN2 | |
| SPKLAASPKPATSPK | 1036 | Q6ZU65 | |
| ATSPKPLPSPKPSAS | 1046 | Q6ZU65 | |
| KPSASPKPSLSAKPS | 1056 | Q6ZU65 | |
| ISKSNPTPKPTVSPS | 1076 | Q6ZU65 | |
| TSSPPVTPKKLFTSP | 1301 | Q7Z2Z1 | |
| PKPPASLKSTKSATP | 26 | B3KS81 | |
| SRPPPAKPQLSTAKS | 31 | Q8NER1 | |
| LLTESPPTPLSKTNK | 231 | Q02086 | |
| SHSPPPKQRSSPVTK | 636 | Q8IYB3 | |
| TSSFLKSPTPPPSSK | 486 | Q8NEM7 | |
| PPSSKPSSIPRKSSV | 496 | Q8NEM7 | |
| IPPPLSDTTKPKSSL | 416 | Q9Y6W5 | |
| TSPSSPLPVKVSLKP | 1056 | Q70CQ4 | |
| KSLSVPAASTAKPPP | 1251 | P49815 | |
| KRDSSTQPPKSAKPP | 771 | Q86VM9 | |
| PIAPTATLLSKKTPA | 1526 | E9PAV3 |